Giant gastrointestinal stromal tumor of the stomach: a challenging diagnostic and therapeutically approach

被引:0
作者
Bara, Tivadar [1 ]
Jung, Ioan [2 ]
Gurzu, Simona [2 ]
Kadar, Zoltan [2 ,3 ]
Koevecsi, Attila [2 ]
Bara, Tivadar, Jr. [1 ]
机构
[1] Univ Med & Pharm Tirgu Mures, Dept Surg, Targu Mures 540139, Romania
[2] Univ Med & Pharm Tirgu Mures, Dept Pathol, Targu Mures 540139, Romania
[3] Univ Med & Pharm Tirgu Mures, Dept Oncol, Targu Mures 540139, Romania
关键词
gastrointestinal stromal tumor; malignant potential; therapy; maspin; E-cadherin; DOG-1; EXPRESSION;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gastrointestinal stromal tumors (GISTs) are rare but challenging tumors regarding the diagnosis and therapy. The symptomatology depends on the tumor size and location, and can be totally non-specific, as in the present case. We present the case of a 76-year-old female that was hospitalized with postprandial nausea and vomiting. Bulging of the posterior wall of the stomach was seen at endoscopically examination and confirmed by the computed tomography. Surgical resection of the 120x100 mm-sized tumor that involved the posterior gastric wall and gastrocolic ligament, was performed; the posterior wall of the stomach was also partially excised. Histological examination revealed a 120x95x70 mm nodular tumor with solid aspect and large necrotic and hemorrhagic area on cut section. The tumor cells were marked by c-KIT, DOG-1, smooth muscle actin and MSH-2 and were negative for Ki67, maspin, E-cadherin, S-100, and keratin AE1/AE3. The resection margins were free of tumor cells. No recurrences were reported three years after surgical intervention; no postoperative chemotherapy was performed. This case highlights that a well-conducted trans-disciplinary approach can have real benefits, even in borderline-operable giant potentially-malignant GISTs. New criteria to establish the malignant potential of GIST should be explored.
引用
收藏
页码:1503 / 1506
页数:4
相关论文
共 17 条
  • [1] [Anonymous], 2007, J NATL COMPR CANC NE
  • [2] Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
    Bauer, S
    Corless, CL
    Heinrich, MC
    Dirsch, O
    Antoch, G
    Kanja, J
    Seeber, S
    Schütte, J
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) : 261 - 265
  • [3] Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with imatinib
    de Silva, MV
    Reid, R
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (01) : 13 - 19
  • [4] Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival
    DeMatteo, RP
    Lewis, JJ
    Leung, D
    Mudan, SS
    Woodruff, JM
    Brennan, MF
    [J]. ANNALS OF SURGERY, 2000, 231 (01) : 51 - 58
  • [5] Demetri George D, 2007, J Natl Compr Canc Netw, V5 Suppl 2, pS1
  • [6] Fletcher CD, 2013, PATHOLOGY GENETICS T
  • [7] Kinase Genotype Analysis of Gastric Gastrointestinal Stromal Tumor Cytology Samples Using Targeted Next-Generation Sequencing
    Gleeson, Ferga C.
    Kipp, Benjamin R.
    Kerr, Sarah E.
    Voss, Jesse S.
    Graham, Rondell P.
    Campion, Michael B.
    Minot, Douglas M.
    Tu, Zheng J.
    Klee, Eric W.
    Lazaridis, Konstantinos N.
    Henry, Michael R.
    Levy, Michael J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 202 - 206
  • [8] Mesenchymal-to-Endothelial Transition in Kaposi Sarcoma: A Histogenetic Hypothesis Based on a Case Series and Literature Review
    Gurzu, Simona
    Ciortea, Diana
    Munteanu, Teodora
    Kezdi-Zaharia, Iringo
    Jung, Ioan
    [J]. PLOS ONE, 2013, 8 (08):
  • [9] Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms
    Hemminger, Jessica
    Iwenofu, O. Hans
    [J]. HISTOPATHOLOGY, 2012, 61 (02) : 170 - 177
  • [10] DOG1 Antibody Is a Highly Sensitive and Specific Marker for Gastrointestinal Stromal Tumors in Cytology Cell Blocks
    Hwang, Dick G.
    Qian, Xiaohua
    Hornick, Jason L.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (03) : 448 - 453